BIOAVIVUS, Inc.

NE201, Phase Two drug to treat OSAS.

  • Stage Not Set
  • Industry Biotechnology
  • Location Champaign, IL, USA
  • Currency USD

Company Summary

Utilizing Nanotechnology to make ordinary drugs extraordinary therapies. Our therapy will effectively treat the underlying pathology of OSAS , reduce the morbidity and mortality associated with this lethal disease.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free